[EN] TRIAZOLE BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS<br/>[FR] DÉRIVÉS DE LA BÊTA CARBOLINE TRIAZOLE CONSTITUANT DES COMPOSÉS ANTIDIABÉTIQUES
申请人:MERCK SHARP & DOHME
公开号:WO2010051177A1
公开(公告)日:2010-05-06
Beta-carboline derivatives of structural formula (I) are selective antagonists of the somatostatin subtype receptor 3 (SSTR3) and are useful for the treatment of Type 2 diabetes mellitus and of conditions that are often associated with this disease, including hyperglycemia, insulin resistance, obesity, lipid disorders, and hypertension. The compounds are also useful for the treatment of depression and anxiety.
结构式(I)的β-咔啉衍生物是生长抑素亚型受体3 (SSTR3)的选择性拮抗剂,可用于治疗2型糖尿病以及通常与该疾病相关的病症,包括高血糖、胰岛素抵抗、肥胖、脂质紊乱和高血压。这些化合物还可用于治疗抑郁症和焦虑症。